课题基金 / 基金详情

项目摘要

项目成果

K ALLEN GREINER的其他基金

相似基金

相关文献

中文摘要
翻译
摘要/摘要 这一多样性补充的候选人是议员威廉·托德·摩尔,目前是 堪萨斯大学医学中心(KUMC)家庭医学系。摩尔先生是一个 堪萨斯大学博士后。摩尔先生的长期职业目标是成为一名 独立资助的研究人员专注于癌症控制、人口健康和 代表性不足的人群。摩尔先生将接受学术培训、有指导的研究和职业生涯 通过这一补充进行发展培训,将有助于他实现这一长期目标。 本增刊的目的是让摩尔先生:1)接受概念化培训, 实施和分析行为干预研究2)增加与社会和社会相关的知识 环境因素对代表不足的少数族裔(URM)患者癌症相关预后的影响 和社区卫生工作者(CHW),以及3)建立学术出版物和赠款的跟踪记录 需要启动一项关于癌症相关健康差异的独立研究计划。他将会完成 这些研究目标是在艾伦·格雷纳博士的指导下,在家长R01的指导下,牵头进行的 包含在父母资助范围内的项目,完成正式课程和研讨会,以及 在国家会议上发表演讲,以建立他的技能和研究网络。这份多样性副刊将 为摩尔先生提供过渡到未来博士后工作所需的培训,并提供 最终作为一名成功的研究人员,在行为科学、CBPR和临床试验之间架起桥梁 对代表不足的少数民族(URM)人群的研究。这项拟议中的研究结果将提高马多夫的实力。 摩尔有能力让更多的URM参与癌症临床试验研究,提高他提高认识的能力 少数族裔中的癌症,并直接制定干预措施,以减少这一领域的癌症差异 随着人口的持续增长和老龄化,人口也在不断增加。 具体目标1:为社区妇女制定和提供文化敏感度和语言适切的干预 在安全网诊所对拒绝参加家长R01的合格患者进行筛查 研究,但需要额外注意的人,以促进CRC筛查。 具体目标2:开发一种与CHW的干预措施,使他们也能够促进癌症研究 医疗机构高度不信任和对研究持负面意见的安全网临床患者。
英文摘要
Abstract/Summary The candidate for this diversity supplement is William Todd Moore, MPS, currently a project director in the Department of Family Medicine at the University of Kansas Medical Center (KUMC). Mr. Moore is a predoctoral student at the University of Kansas. Mr. Moore's long-term career goal is to become an independently-funded researcher focused on cancer control, population health and health disparities among underrepresented populations. Mr. Moore will receive academic training, mentored research and career development training through this supplement that will assist him in achieving this long-term goal. The goals of this supplement are for Mr. Moore to: 1) receive training in the conceptualization, implementation, and analysis of behavioral intervention studies 2) increase his knowledge related to social and environmental factors impacting cancer-related outcomes among underrepresented minority (URM) patients and community health workers (CHW), and 3) establish a track record of scholarly publications and grants needed to launch an independent research program in cancer related health disparities. He will accomplish these research goals under the mentorship of Dr. Allen Greiner on the parent R01, taking the lead on a sub- project contained within the scope of the parent grant, completing formal courses and seminars, and presenting at national conferences to build his skills and research network. This Diversity Supplement will provide Mr. Moore with the training necessary for him to transition into future postdoctoral work and an eventual role as a successful researcher that can bridge behavioral sciences, CBPR, and clinical trials research to underrepresented minority (URM) populations. Findings from the proposed study will enhance Mr. Moore's ability to engage more URMs in cancer clinical trials research, boost his ability to raise awareness of cancer among minorities, and direct development of interventions to reduce cancer disparities in this population as it continues to grow and age demographically. Specific Aim 1: To develop and deliver a culturally sensitivity and language appropriate intervention for CHWs to deliver with screening eligible patients at safety net clinics who have declined enrollment in the parent R01 study but who need additional attention to facilitate CRC screening. Specific Aim 2: To develop an intervention with CHWs that allows them to also promote cancer research to safety-net clinic patients with high levels of institutional distrust and negative opinions of research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
KanSurvive: Testing a model for improving cancer survivorship care in rural practice
KanSurvive: Testing a model for improving cancer survivorship care in rural practice
KanSurvive: Testing a model for improving cancer survivorship care in rural practice
KanSurvive: Testing a model for improving cancer survivorship care in rural practice
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: